APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated NephropathyJeffrey B. Kopp, Cheryl A. Winkler, David J. Friedman et al.|Journal of the American Society of Nephrology|2011Cited by 856
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisJeffrey B. Kopp, Cheryl A. Winkler, Michael W. Smith et al.|Nature Genetics|2008Cited by 706
Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureZenji Makita, Jonathan Winston, Richard Bucala et al.|The Lancet|1994Cited by 372